Abbott has recently launched Similac High Energy, a Food for Special Medical Purposes (FSMP), available on prescription for infants with, or at risk of, faltering growth. Faltering growth describes infants or young children who do not achieve a normal or expected rate of growth, or experience unplanned weight loss.

There has been much media interest in a recent study of post-menopausal women which concluded that using multivitamins has little or no effect on total mortality, or the risk of cancer or cardiovascular disease. Dr Carrie Ruxton, Health Supplement's Information Service looks at the pros and cons.